Get the Stockscreener App
7.61
4.46%
0.325
After Hours:
7.64
0.03
+0.39%
Tenax Therapeutics Inc stock is traded at $7.61, with a volume of 169.36K.
It is up +4.46% in the last 24 hours and up +27.05% over the past month.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
See More
Previous Close:
$7.285
Open:
$7.22
24h Volume:
169.36K
Relative Volume:
3.54
Market Cap:
$34.72M
Revenue:
-
Net Income/Loss:
$-14.56M
P/E Ratio:
-0.4524
EPS:
-16.82
Net Cash Flow:
$-12.46M
1W Performance:
+16.54%
1M Performance:
+27.05%
6M Performance:
+16.18%
1Y Performance:
+119.94%
1-Day Range:
$7.22
$7.81
1-Week Range:
$6.48
$7.81
52-Week Range:
$3.25
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Name
Tenax Therapeutics Inc
Sector
Industry
Phone
919-855-2100
Address
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
7.61 | 33.24M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Piper Sandler | Overweight |
| Oct-24-24 | Initiated | Leerink Partners | Outperform |
| Oct-14-24 | Initiated | Guggenheim | Buy |
| Sep-30-24 | Initiated | William Blair | Outperform |
| May-18-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-16-14 | Initiated | MLV & Co | Buy |
| Nov-18-14 | Initiated | WallachBeth | Buy |
View All
Tenax Therapeutics Inc Stock (TENX) Latest News
Is Tenax Therapeutics Inc. stock a dividend growth opportunityMarket Growth Review & Capital Protection Trading Alerts - newser.com
Detecting price anomalies in Tenax Therapeutics Inc. with AIMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Can you recover from losses in Tenax Therapeutics Inc.Market Activity Report & High Accuracy Buy Signal Tips - newser.com
Exit strategy if you’re trapped in Tenax Therapeutics Inc.Watch List & Accurate Technical Buy Alerts - newser.com
What drives Mitsubishi Corporation Common Stock MBI1 stock priceRisk Mitigation Techniques & Big Gains Low Cost - earlytimes.in
What drives Tenax Therapeutics Inc stock priceGrowth vs. Value Investing & Market Volatility Strategies - earlytimes.in
Risk vs reward if holding onto Tenax Therapeutics Inc.Product Launch & High Return Stock Watch Alerts - newser.com
What moving averages say about Tenax Therapeutics Inc.2025 Technical Overview & Weekly High Return Forecasts - newser.com
Real time alert setup for Tenax Therapeutics Inc. performanceMarket Growth Summary & Expert Curated Trade Ideas - newser.com
How hedge fund analytics apply to Tenax Therapeutics Inc. stockEarnings Beat & Technical Entry and Exit Alerts - newser.com
Using data models to predict Tenax Therapeutics Inc. stock movementDollar Strength & Reliable Breakout Forecasts - newser.com
Will Tenax Therapeutics Inc. stock benefit from green energy trends2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Tenax Therapeutics (NASDAQ:TENX) Stock Passes Above 200 Day Moving Average – Here’s Why - Defense World
Best data tools to analyze Tenax Therapeutics Inc. stockJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
Real time social sentiment graph for Tenax Therapeutics Inc.Weekly Profit Recap & Verified Technical Trade Signals - newser.com
Aug Patterns: Is Tenax Therapeutics Inc still a buy after recent gainsMarket Growth Review & Real-Time Volume Analysis Alerts - خودرو بانک
Is Tenax Therapeutics Inc still a buy after recent gainsMarket Growth Review & Real-Time Volume Analysis Alerts - خودرو بانک
Quantitative breakdown of Tenax Therapeutics Inc. recent move2025 Technical Overview & Safe Entry Zone Identification - newser.com
Is Tenax Therapeutics Inc. trending in predictive chart modelsEarnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
How to track smart money flows in Tenax Therapeutics Inc.July 2025 Price Swings & Accurate Intraday Trading Signals - newser.com
Risk Analysis: What hedge funds are buying Tenax Therapeutics IncWeekly Trend Summary & Consistent Profit Trading Strategies - khodrobank.com
Chart based exit strategy for Tenax Therapeutics Inc.July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Stock Analysis: Is Tenax Therapeutics Inc impacted by rising rates2025 Historical Comparison & Step-by-Step Trade Execution Guides - خودرو بانک
What drives Tenax Therapeutics Inc.’s stock price2025 Key Lessons & Real-Time Buy Signal Notifications - khodrobank.com
Tenax Therapeutics Inc Stock (TENX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):